Form4insider filings, from the source

SEC Form 4 · accession 0000921895-15-002829

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Dec 17, 2015
Accepted (ET)
Dec 18, 2015 · 5:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F4Dec 17, 2015P6,962$6.01A31,040IBy: Separately Managed Account
Common StockF1,F4Dec 18, 2015P1,070$6.01A32,110IBy: Separately Managed Account
Common StockF1,F2holding———555,588IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses